# Chidamide With CHOP Regimen for de Novo PTCL Patients (CHOP: Cyclophosphamide, Etoposide, Vincristine and Prednisone; PTCL: Peripheral T Cell Lymphoma)

> **NCT03268889** · NA · UNKNOWN · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 39 (estimated)

## Conditions studied

- Peripheral T Cell Lymphoma

## Interventions

- **DRUG:** Chidamide

## Key facts

- **NCT ID:** NCT03268889
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-15
- **Primary completion:** 2020-06-15
- **Final completion:** 2020-09-15
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2017-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03268889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03268889, "Chidamide With CHOP Regimen for de Novo PTCL Patients (CHOP: Cyclophosphamide, Etoposide, Vincristine and Prednisone; PTCL: Peripheral T Cell Lymphoma)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03268889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*